Trial Profile
Efficacy and Safety of VIVITROL® (Naltrexone for Extended-release Injectable Suspension) in Adults With Opioid Dependence
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Sep 2014
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary)
- Indications Opioid-related disorders
- Focus Therapeutic Use
- Sponsors Alkermes plc
- 10 Sep 2014 New trial record